Synlogic (SYBX) Tops Q4 EPS by 7c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq futures tick up as tech steadies, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Synlogic Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
March 12, 2019 7:00 AM EDTEnded 2018 with approximately $123 million in cash and investments, which provides runway through 2020
Clinical trial readouts expected in mid-2019 from two Synthetic Biotic medicines and first IND application expected from Synlogics immuno-oncology platform in second half of 2019
Company will host a conference call and webcast at 8:00 am ET today
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Synlogic, Inc.... More
